The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 611-618

  Hashikata, Atsushi ^a   Yamashita, Akiko ^a   Suzuki, Shigeki ^a   Nagayasu, Shintaro ^a   Shinjo, Takanori ^a   Taniguchi, Ataru ^b   Fukushima, Mitsuo ^c   Nakai, Yoshikatsu ^d   Nin, Kazuko ^e   Watanabe, Naoya ^f   Asano, Tomoichiro ^a   Abiko, Yoshimitsu ^g   Kushiyama, Akifumi ^h   Nagasaka, Shoichiro ⁱ   Nishimura, Fusanori ^a,j  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kyoto Preventive Medical Center   (Japan)

^c OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^d Kyoto Institute of Health Science   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^g NIHON UNIVERSITY   (Japan)

^h INSTITUTE FOR ADULT DISEASES   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

CKD; Inflammation; Lipocalin 2; Macrophages; Mesangial cells

Indexed keywords

CREATININE; ENDOTOXIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; URIC ACID; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; TNFRSF1B PROTEIN, HUMAN; TRANSCRIPTOME;

ADULT; AGED; ANIMAL CELL; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; UPREGULATION; VERY ELDERLY; ANIMAL; BLOOD; CELL LINE; CHRONIC KIDNEY FAILURE; COCULTURE; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CELL LINE; COCULTURE TECHNIQUES; CREATININE; FEMALE; HUMANS; INFLAMMATION; LIPOCALINS; MALE; MICE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RENAL INSUFFICIENCY, CHRONIC; TRANSCRIPTOME;

EID: 84895730519     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft449     Document Type: Article

References (31)

1. Samak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003; 41(Suppl 5): 11-17
2. Gross ML, Dicow R, Ritz E. Diabetic nephropathy: recent insights into the pathophysiology and the progression of diabetic nephropathy. Kidney Int Suppl 2005; 41: S50-S53
3. Cirillo P, Sautin YY, Kanellis J et al. Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant 2009; 24: 1384-1387
4. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414
5. Kon V, Linton MF, Fazio S. Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol 2011; 7: 45-54
6. Navarro JF, Mora-Femá C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 2006; 17: 441-450
7. Izumi Y, Yabe D, Taniguchi A et al. Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes. Diab Res Clin Pract 2013; 99: 145-150
8. Vielhauer V, Stavrakis G, Mayadas T. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005; 115: 1199-1209
9. Upadhyay A, Larson MG, Guo CY et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant 2011; 26: 920-926
10. Kawasaki Y, Taniguchi A, Fukushima M et al. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm Metab Res 2005; 37: 617-621
11. Alberi KG, Zimmeret PZ. Definition, diagnosis, and classification of diabetes and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 1998; 15: 539-553
12. Taniguchi A, Nagasaka S, Fukushima M et al. C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 2001; 51: 1578-1581
13. Yatagai T, Nagasaka S, Taniguchi A et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274-1278
14. Okumura T, Taniguchi A, Nagasaka S et al. Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients. Diabetes Metab 2002; 29: 15-18
15. Taniguchi A, Fukushima M, Nakai Y et al. Soluble tumor necrosis factor receptor 1 is strongly and independently associated with serum homocysteine in nonobese Japanese type 2 diabetic patients. Diabetes Care 2006; 29: 949-950
16. Ohya M, Taniguchi A, Fukushima M et al. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism 2005; 54: 1297-1301
17. Seino Y, Nanjo K, Tajima N et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010; 1: 212-228
18. Imai E, Horio M, Nitta K et al. Modification of the modification of diet in renal disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 44: 923-927
19. Femáandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301
20. Yamashita A, Soga Y, Iwamoto Y et al. DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW 264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin. Int J Obese 2008; 32: 1725-1729
21. Schmidt-Ott KM, Mori K, Li JY et al. Dual action of neutrophil gelatinaseassociated lipocalin. J Am Soc Nephrol 2007; 18: 407-413
22. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinaseassociated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 337-344
23. Woo K-S, Choi J-L, Kim B-R et al. Urinary neutrophil gelatinaseassociated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease. Diabetes Metab J 2012; 36: 307-313
24. Ding H, He Y, Li K et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007; 123: 227-234
25. Nickolas TL, Forster C, Sise ME et al. Monomeric neutrophil gelatinase associated lipocalin is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int 2012; 82: 718-722
26. Viau A, Karoui KE, Laouari D et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010; 120: 4065-4076
27. Lim AKH, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm 2012; 2012: 146154
28. Kopp JB. Rethinking hypertensive kidney disease: arterionephrosclerosis as genetic, metabolic, and inflammatory disorder. Curr Opin Nephrol Hypertens 2013 Epub ahead of print (PMID: 23470819)
29. Buemi M, Senatore S, Corica F et al. Statins and progressive renal disease. Medicinal Res Rev 2002; 22: 76-84
30. Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011; 80: 915-925
31. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 2010; 87: 989-999